Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05282901
Title Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) (PLUME)
Acronym PLUME
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Curie
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.